Pharmacokinetics of Afamelanotide in EPP Patients

Updated 06/21/2024

Status Recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Erythropoietic Protoporphyria

Clinical Trial Details

NCT number	NCT06388642
Study type	Interventional
Source	Clinuvel Pharmaceuticals Limited
Contact	Head of Clinical Operations
Phone	+441372860765
Email	mail@clinuvel.com
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	March 7, 2024
Completion date	October 1, 2024

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00979745` - Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)	Phase 3
	Active, not recruiting	`NCT05308472` - Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP	Phase 2
	Completed	`NCT00004831` - Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria	N/A
	Completed	`NCT05572125` - Iron Therapy in Erythropoietic Protoporphyria
	Completed	`NCT01605136` - Phase III Confirmatory Study in Erythropoietic Protoporphyria	Phase 3
	Completed	`NCT01422915` - Sorbent Therapy of the Cutaneous Porphyrias	Phase 2/Phase 3
	Completed	`NCT04053270` - Multicentre Phase III Erythropoietic Protoporphyria Study	Phase 3
	Completed	`NCT00004940` - Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria	Phase 3
	Recruiting	`NCT05020184` - Effect of Oral Cimetidine in the Protoporphyrias	Phase 2
	Completed	`NCT01688895` - Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
	Completed	`NCT04578496` - A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)	Phase 3
	Recruiting	`NCT00206869` - Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria	N/A
	Recruiting	`NCT05780840` - Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria	N/A
	Completed	`NCT02979249` - Oral Iron for Erythropoietic Protoporphyrias	N/A
	Enrolling by invitation	`NCT05883748` - Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP	Phase 2/Phase 3
	Completed	`NCT01097044` - Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)	Phase 2
	Completed	`NCT03682731` - Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria